catechin and aspirin

catechin has been researched along with aspirin in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19905 (21.74)18.7374
1990's3 (13.04)18.2507
2000's7 (30.43)29.6817
2010's6 (26.09)24.3611
2020's2 (8.70)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Carbonneau, MA; Cartron, E; Descomps, B; Fouret, G; Léger, CL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Bohlin, L; Danielson, H; Noreen, Y; Perera, P; Ringbom, T1
Bohlin, L; el-Seedi, H; Noreen, Y; Perera, P1
Backlund, A; Bohlin, L; Gottfries, J; Larsson, J1
Chang, FR; Hwang, TL; Lee, CL; Liao, YC; Wu, CC; Wu, YC1
Li, J; Li, N; Ling, J; Tang, Y; Wang, W; Zhang, N; Zhang, P; Zhang, X1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Brzozowski, T; Kitler, ME; Konturek, SJ; Radecki, T1
Kitler, ME; Konturek, SJ; Kopp, B; Kwiecien, N; Obtulowicz, W; Oleksy, J1
Hennings, G; Parmar, NS1
Ganote, DP; Hennings, G; Lücker, PW1
Ghosh, MN; Parmar, NS1
Chung, KH; Kang, WS; Lim, IH; Park, JB; Yoo, HS; Yuk, DY; Yun, YP1
Gusak, VK; Il'iushchenko, SV; Iurchuk, AIu; Rodin, IuV; Shtutin, AA1
Gosselin, R; Holt, RR; Keen, CL; Paglieroni, TG; Pearson, DA; Rein, D; Schmitz, HH; Schramm, DD; Wang, JF; Wun, T1
Alayash, AI; Jia, Y1
Burnett, BP; Jia, Q; Levy, RM; Pillai, L; Yimam, M; Zhao, Y1
McCarty, MF1
Cho, JY; Hong, SJ; Joo, HJ; Kim, KA; Lee, SH; Lim, DS; Park, JH; Park, JY; Yu, CW1
Chang, WL; Clapper, ML; Cooper, HS1

Reviews

2 review(s) available for catechin and aspirin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
    Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:3

    Topics: Aberrant Crypt Foci; Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Aspirin; Atorvastatin; Carcinogenesis; Catechin; Clinical Trials as Topic; Colon; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Mucosa; Lycopene; Mice; Mutation; Treatment Outcome

2020

Trials

4 trial(s) available for catechin and aspirin

ArticleYear
[Application of preparation endotelon in complex treatment of chronic arterial insufficiency of lower extremities].
    Klinichna khirurhiia, 2000, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arterial Occlusive Diseases; Aspirin; Biflavonoids; Catechin; Drug Therapy, Combination; Female; Humans; Ischemia; Leg; Male; Middle Aged; Platelet Aggregation Inhibitors; Proanthocyanidins; Ticlopidine; Treatment Outcome

2000
The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function.
    Thrombosis research, 2002, May-15, Volume: 106, Issue:4-5

    Topics: Adult; Antibodies, Monoclonal; Aspirin; Blood Coagulation Tests; Cacao; Catechin; Cross-Over Studies; Female; Flavonoids; Humans; Male; Middle Aged; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex

2002
Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies.
    Advances in therapy, 2010, Volume: 27, Issue:6

    Topics: Adult; Aged; Animals; Anticoagulants; Arachidonate 5-Lipoxygenase; Aspirin; Bleeding Time; Catechin; Cyclooxygenase 1; Cyclooxygenase 2; Drug Combinations; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Mice; Mice, Inbred ICR; Middle Aged; Osteoarthritis; Platelet Aggregation

2010
Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment.
    The Korean journal of internal medicine, 2018, Volume: 33, Issue:3

    Topics: Adult; Aged; Aspirin; Blood Platelets; Catechin; Clopidogrel; Coronary Stenosis; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Republic of Korea; Ticagrelor; Ticlopidine

2018

Other Studies

17 other study(ies) available for catechin and aspirin

ArticleYear
Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production.
    Journal of natural products, 2001, Volume: 64, Issue:4

    Topics: Antioxidants; Caffeic Acids; Humans; Inflammation Mediators; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phenols

2001
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis.
    Journal of natural products, 1998, Volume: 61, Issue:1

    Topics: Animals; Biological Assay; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Kinetics; Placenta; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Sheep

1998
Two new isoflavones from Ceiba pentandra and their effect on cyclooxygenase-catalyzed prostaglandin biosynthesis.
    Journal of natural products, 1998, Volume: 61, Issue:1

    Topics: Animals; Cattle; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Glucosides; Isoenzymes; Isoflavones; Magnetic Resonance Spectroscopy; Plant Epidermis; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet

1998
Expanding the ChemGPS chemical space with natural products.
    Journal of natural products, 2005, Volume: 68, Issue:7

    Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship

2005
Ixorapeptide I and ixorapeptide II, bioactive peptides isolated from Ixora coccinea.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Cell Line, Tumor; Humans; Kaempferols; Luteolin; Magnetic Resonance Spectroscopy; Molecular Conformation; Pancreatic Elastase; Peptides; Platelet Aggregation Inhibitors; Rubiaceae; Structure-Activity Relationship; Superoxides

2010
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
    Bioorganic & medicinal chemistry letters, 2015, Aug-15, Volume: 25, Issue:16

    Topics: Animals; Bauhinia; Blood Platelets; Flavonoids; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Medicine, Chinese Traditional; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Structure-Activity Relationship

2015
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Gastric protection by meciadanol. A new synthetic flavonoid inhibiting histidine decarboxylase.
    Digestive diseases and sciences, 1986, Volume: 31, Issue:8

    Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Ulcer Agents; Aspirin; Benzopyrans; Carboxy-Lyases; Catechin; Epoprostenol; Ethanol; Female; Gastric Acid; Gastric Mucosa; Histidine Decarboxylase; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Time Factors

1986
Effect of meciadanol on gastric secretion and aspirin-induced gastric mucosal injury in humans.
    Scandinavian journal of gastroenterology, 1984, Volume: 19, Issue:8

    Topics: Adult; Aspirin; Benzopyrans; Catechin; DNA; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Histamine; Humans; Pepsin A

1984
The effect of 3-methoxy-5,7,3',4'-tetrahydroxyflavan on the restraint induced gastric ulceration augmented by aspirin, a gastric mucosal barrier breaker.
    Research communications in chemical pathology and pharmacology, 1983, Volume: 41, Issue:2

    Topics: Animals; Anti-Ulcer Agents; Aspirin; Catechin; Cimetidine; Flavonoids; Gastric Mucosa; Male; Rats; Restraint, Physical; Stomach Ulcer

1983
3-Methoxy-5,7,3',4'-tetrahydroxyflavan (ME): a new compound to prevent gastric irritation. A gastric potential difference analysis.
    Methods and findings in experimental and clinical pharmacology, 1983, Volume: 5, Issue:7

    Topics: Aspirin; Catechin; Dose-Response Relationship, Drug; Flavonoids; Gastric Mucosa; Humans; Irritants; Male; Membrane Potentials; Random Allocation; Stomach Diseases

1983
Gastric anti-ulcer activity of (+)-cyanidanol-3, a histidine decarboxylase inhibitor.
    European journal of pharmacology, 1981, Jan-05, Volume: 69, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Aspirin; Benzopyrans; Carboxy-Lyases; Catechin; Female; Gastric Acidity Determination; Gastric Mucosa; Histidine Decarboxylase; Ibuprofen; Male; Phenylbutazone; Rats; Reserpine; Restraint, Physical; Stomach Ulcer

1981
Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate.
    Thrombosis research, 1999, Nov-01, Volume: 96, Issue:3

    Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Calcimycin; Calcium; Catechin; Collagen; Epinephrine; Fibrinolytic Agents; Humans; Ion Transport; Ionophores; Male; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Tea

1999
Effects of (-)-epigallocatechin gallate on the redox reactions of human hemoglobin.
    Free radical biology & medicine, 2008, Sep-01, Volume: 45, Issue:5

    Topics: Aspirin; Catechin; Cross-Linking Reagents; Hemoglobins; Humans; Oxidation-Reduction

2008
Dietary nitrate and reductive polyphenols may potentiate the vascular benefit and alleviate the ulcerative risk of low-dose aspirin.
    Medical hypotheses, 2013, Volume: 80, Issue:2

    Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Catechin; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Models, Biological; Nitrates; Nitric Oxide; Polyphenols; Quercetin

2013